Immediate Impact
4 from Science/Nature 70 standout
Citing Papers
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
FXR agonists in NASH treatment
2023 Standout
Works of Hubert Hayden being referenced
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
2016
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Hubert Hayden | 133 | 121 | 230 | 457 | 416 | 33 | 900 | |
| Kei Moriya | 123 | 94 | 351 | 464 | 338 | 61 | 1.1k | |
| Masami Asakawa | 100 | 99 | 139 | 346 | 404 | 19 | 826 | |
| Emanuele Bendia | 74 | 68 | 264 | 359 | 341 | 34 | 1.1k | |
| Christian J. Steib | 83 | 163 | 173 | 360 | 367 | 43 | 851 | |
| Kenichiro Mikami | 82 | 82 | 260 | 358 | 302 | 37 | 805 | |
| Marco Biolato | 91 | 125 | 130 | 440 | 409 | 50 | 929 | |
| Jing Hou | 94 | 118 | 323 | 505 | 172 | 27 | 1.1k | |
| Karen Wallace | 124 | 84 | 246 | 332 | 440 | 23 | 895 | |
| Keishi Kanno | 159 | 69 | 354 | 348 | 191 | 63 | 1.0k | |
| Carlos M. Rodríguez‐Ortigosa | 170 | 95 | 379 | 260 | 274 | 39 | 1.1k |
All Works
Loading papers...